Cleopatra Hospitals Group results, Q1 2026
Net profit, assets, equity and cash flow for Q1 2026, against the same period a year earlier, from the published financial statements.
Net profit118 millionEGP · −85.7% vs the same period a year earlier
Total assets10.98 billionEGP · +25.1% vs the same period a year earlier
Shareholders' equity4.21 billionEGP · +22.4% vs the same period a year earlier
Operating cash flow554 millionEGP · +194.9% vs the same period a year earlier
In short
- Cleopatra Hospitals Group's net profit for Q1 2026 was about 118 million EGP, down −85.7% from 824 million EGP in Q1 2025.
- Total assets at the end of Q1 2026 were about 10.98 billion EGP, and shareholders' equity about 4.21 billion EGP.
- Operating cash flow for Q1 2026 was positive at 554 million EGP.
Key lines against the same period a year earlier
This periodQ1 2025Change
Net profit118 million824 million−85.7%
Gross profit763 million3.08 billion−75.2%
Total assets10.98 billion8.78 billion+25.1%
Total liabilities6.78 billion5.34 billion+26.9%
Shareholders' equity4.21 billion3.44 billion+22.4%
Total liabilities and equity10.98 billion8.78 billion+25.1%
Operating cash flow554 million188 million+194.9%
Investing cash flow-507 million-407 million−24.6%
Financing cash flow183 million137 million+33.7%
Net change in cash230 million223 million+3.1%
Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version. Figures are as shown in the published statement summary; quarterly figures may be cumulative from the start of the fiscal year.
Cleopatra Hospitals Group's Q3 2026 results, the day they are published
One email on the day, no account, and a one-click stop in the email itself.
By subscribing you agree to receive these alerts only. Privacy policy